Aileron Therapeutics Inc (NQ: ALRN )
2.990
-0.100
(-3.24%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 17, 2024
Add to My Watchlist
All News about Aileron Therapeutics Inc
![](https://cdn.benzinga.com/files/images/story/2023/02/21/image24.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/02/21/image14.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/02/21/alrn_logo_light__fe1fe357300c618d6ff9411bf9a464e2.png?width=1200&height=800&fit=crop)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
12 Health Care Stocks Moving In Tuesday's Intraday Session
February 21, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/02/21/image38.jpeg?width=1200&height=800&fit=crop)
Dow Tumbles More Than 500 Points; US Manufacturing PMI Rises In February
February 21, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/02/21/image-walmart.jpg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/0f820a8e-3c6b-47d8-bbd1-78d7a9ae490d/small/aileron-logo-png.png)
![](https://ml.globenewswire.com/media/0f820a8e-3c6b-47d8-bbd1-78d7a9ae490d/small/aileron-logo-png.png)
Aileron Therapeutics Regains Compliance with Nasdaq Listing Requirements
November 30, 2022
Via GlobeNewswire
![](https://ml.globenewswire.com/media/0f820a8e-3c6b-47d8-bbd1-78d7a9ae490d/small/aileron-logo-png.png)
![](https://ml.globenewswire.com/media/0f820a8e-3c6b-47d8-bbd1-78d7a9ae490d/small/aileron-logo-png.png)
![](https://ml.globenewswire.com/media/0f820a8e-3c6b-47d8-bbd1-78d7a9ae490d/small/aileron-logo-png.png)
![](https://ml.globenewswire.com/media/0f820a8e-3c6b-47d8-bbd1-78d7a9ae490d/small/aileron-logo-png.png)
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_17340.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/15/image_2.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_15579.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/09/image_3.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_14277.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/08/image46.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_14215.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/05/image_1.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_13723.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/03/image30.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_13860.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_11453.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/02/image-applied-dna-sciences.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/02/image-revlon.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_13755.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/07/15/image11_0.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/07/01/image11.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/06/30/image34.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.